Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Aug 10, 2011; 2(8): 303-310
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303
Expected clinical applications of circulating tumor cells in breast cancer
Youngjin Park, Tomoaki Kitahara, Tasuku Urita, Yutaka Yoshida, Ryoji Kato, Department of Surgery, Sakura Medical Center, School of Medicine, Faculty of Medicine, Toho University, Sakura, Chiba Prefecture 285-8741, Japan
Author contributions: Park Y designed the concept for this study; Kitahara T, Urita T and Yoshida Y acquired the data; Park Y, Kitahara T, Urita T, Yoshida Y and Kato R analysed and interpreted the data; Park Y drafted the manuscript; Park Y, Kitahara T, Urita T, Yoshida Y and Kato R critically revised the manuscript for important intellectual content; Kato R supervised the study.
Correspondence to: Youngjin Park, MD, PhD, Associate Professor (Breast Surgery), Department of Surgery, Sakura Medical Center, School of Medicine, Faculty of Medicine, Toho University, Sakura, Chiba Prefecture 285-8741, Japan. youngjinpark@sakura.med.toho-u.ac.jp
Telephone: +81-43-4628811 Fax: +81-43-4628820
Received: May 31, 2011
Revised: July 7, 2011
Accepted: July 14, 2011
Published online: August 10, 2011
Revised: July 7, 2011
Accepted: July 14, 2011
Published online: August 10, 2011
Core Tip